Matt TurnerPatient Affordability
Joey CohenMedication Adherence
Liz KaneImpactful Strategy
Matthew DurhamOmnidynamic Marketing
Daniel SontupeMarket Access
Stacey GandlerBrand Nourishment
Amy GilesIncreasing Engagement
Frank BurrellScientific Storytelling
Pat PurcellMeeting Engagement
David LinetskyPoint-of-Care Marketing
Paul TheisenPatient Acquisition
Brenda SnowAuthentic Patient Voice
Suma Ramadas, PhDMedical Affairs
Bud BilanichSuccess Coach
TEL-AVIV, Israel and RALEIGH, N.C., May 30, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) ...
Cosentyx® is the first and only IL-17A inhibitor to show sustained improvements in signs ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email